Publications by authors named "James Campling"

Claim this Profile
C
Changes in carriage and serotype diversity of Streptococcus pneumoniae and other respiratory pathobionts in the UK between pre-PCV13 (2006-10), early-PCV13 (2010-12) and late-PCV13 (2012-23) periods.
David W Cleary, Rebecca Anderson, Jessica Jones, Rebecca A Gladstone, Karen L Osman, James Campling

Pneumonia (Nathan)· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emergency department presentations of community-acquired lower respiratory tract disease in Bristol, UK: a prospective cohort study 2022-2023.
Catherine Hyams, Robert Challen, Maria Lahuerta, Elizabeth Begier, Serena McGuinness, James Campling

BMJ Open Respir Res· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimating the burden of vaccine-preventable lower respiratory tract disease in UK primary care: protocol for a prospective surveillance study (AvonCAP GP2).
Polly Duncan, Ruth Mears, Elizabeth Begier, Sanaz Rouhbakhsh Halvaei, Jo Southern, James Campling

BJGP Open· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adult risk groups for vaccine preventable respiratory infections: an overview of the UK environment.
Charles Reynard, James Campling, Adam L Gordon, George Kassianos, Hui-Hsuan Liu

Expert Rev Vaccines· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-pharmaceutical interventions for COVID-19 transiently reduced pneumococcal and carriage in a cross-sectional pediatric cohort in Southampton, UK.
David W Cleary, James Campling, Maria Lahuerta, Kyla Hayford, Jo Southern

Microbiol Spectr· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Surveillance of pneumococcal serotypes in adults hospitalised with acute lower respiratory tract infection in Bristol, UK.
Catherine Hyams, Maria Lahuerta, Christian Theilacker, Jade King, David Adegbite, James Campling

Vaccine· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A review of evidence for pneumococcal vaccination in adults at increased risk of pneumococcal disease: risk group definitions and optimization of vaccination coverage in the United Kingdom.
James Campling, Andrew Vyse, Hui-Hsuan Liu, Hannah Wright, Mary Slack

Expert Rev Vaccines· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of using a 20-valent pneumococcal conjugate vaccine to directly protect adults in England at elevated risk of pneumococcal disease.
Diana Mendes, Ahuva Averin, Mark Atwood, Reiko Sato, Andrew Vyse, James Campling

Expert Rev Pharmacoecon Outcomes Res· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of community acquired lower respiratory tract disease in Bristol, UK during the COVID-19 pandemic: A prospective cohort study.
Catherine Hyams, Robert Challen, Elizabeth Begier, Jo Southern, Jade King, James Campling

Lancet Reg Health Eur· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Public health and budgetary impact of 20-valent pneumococcal conjugate vaccine for adults in England.
Tendai Mugwagwa, Ahuva Averin, Mark Atwood, Reiko Sato, Andrew Vyse, James Campling

Expert Rev Vaccines· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hospitalization costs of adult community-acquired pneumonia in England.
James Campling, Hannah F Wright, Gillian C Hall, Tendai Mugwagwa, Andrew Vyse

J Med Econ· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel approach to estimate the local population denominator to calculate disease incidence for hospital-based health events in England.
James Campling, Elizabeth Begier, Andrew Vyse, Catherine Hyams, Dave Heaton

Epidemiol Infect· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to Dawson et al: Letter to the Editor on ''A review of current data to support decision making for introduction of next generation higher valency pneumococcal conjugate vaccination of immunocompetent older adults in the UK''.
Andrew Vyse, James Campling, Carole Czudek, Gillian Ellsbury, Diana Mendes

Expert Rev Vaccines· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of acute lower respiratory tract disease hospitalisations, including pneumonia, among adults in Bristol, UK, 2019, estimated using both a prospective and retrospective methodology.
Catherine Hyams, Elizabeth Begier, Maria Garcia Gonzalez, Jo Southern, James Campling

BMJ Open· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A review of current data to support decision making for introduction of next generation higher valency pneumococcal conjugate vaccination of immunocompetent older adults in the UK.
Andrew Vyse, James Campling, Carole Czudek, Gillian Ellsbury, Diana Mendes

Expert Rev Vaccines· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identifying UK travellers at increased risk of developing pneumococcal infection: a novel algorithm.
Gillian Ellsbury, James Campling, Harish Madhava, Mary Slack

J Travel Med· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The proportion of contemporary invasive pneumococcal disease and pneumococcal pneumonia in UK adults reflected by serotypes included in the 13-valent pneumococcal conjugate vaccine and next generation higher valency pneumococcal conjugate vaccines in development.
Andrew Vyse, James Campling, Carole Czudek, Gillian Ellsbury, Mary Slack

Vaccine· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Co-diagnoses of acute myeloid leukaemia and COVID-19: presentation and management implications.
Amy O'Brien, James Campling, Hugh Goodman, Catherina L Chang

Respirol Case Rep· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and financial burden of hospitalised community-acquired pneumonia in patients with selected underlying comorbidities in England.
James Campling, Dylan Jones, James Chalmers, Qin Jiang, Andrew Vyse

BMJ Open Respir Res· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Community-acquired pneumonia in the United Kingdom: a call to action.
James Chalmers, James Campling, Gillian Ellsbury, Peter M Hawkey, Harish Madhava

Pneumonia (Nathan)· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Efficacy of Anidulafungin for Fungal Infection in Patients With Liver Dysfunction or Multiorgan Failure.
Anita Verma, Georg Auzinger, Michal Kantecki, James Campling, Dean Spurden

Open Forum Infect Dis· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A systematic review of the burden of vaccine preventable pneumococcal disease in UK adults.
James D Chalmers, James Campling, Alison Dicker, Mark Woodhead, Harish Madhava

BMC Pulm Med· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis